Abstract:Abstract The somatic landscape of the cancer genome results from different mutational processes represented by distinct “mutational signatures.” Although several mutagenic mechanisms are known to cause specific mutational signatures in cell lines, the variation of somatic mutational activities in patients, which is mostly attributed to somatic selection, is still poorly explained. Here, we introduce a quantitative trait, mutational propensity (MP), and describe an integrated method to infer genetic determinants of variations in the mutational processes in 3,566 cancers with specific underlying mechanisms. As a result, we report 2,314 candidate determinants with both significant germline and somatic effects on somatic selection of mutational processes, of which, 485 act via cancer gene expression and 1,427 act through the tumor–immune microenvironment. These data demonstrate that the genetic determinants of MPs provide complementary information to known cancer driver genes, clonal evolution, and clinical biomarkers. Significance: The genetic determinants of the somatic mutational processes in cancer elucidate the biology underlying somatic selection and evolution of cancers and demonstrate complementary predictive power across cancer types.

Supplementary Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Table ST1 from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Table ST3 from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Table ST2 from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Supplemental Material and Methods from an Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Table ST4 from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Supplementary Data from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers

Supplementary Table 14 from A Meta-analysis of Somatic Mutations from Next Generation Sequencing of 241 Melanomas: A Road Map for the Study of Genes with Potential Clinical Relevance

Supplementary Data from <i>a20</i>, &Lt;i>abin-1/2&Lt;/i>, and <i>card11</i> Mutations and Their Prognostic Value in Gastrointestinal Diffuse Large B-Cell Lymphoma

Supplementary Table S3 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Supplementary Data from Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases

Supplementary Figure 4 from A Multiethnic Germline–Somatic Association Database Deciphers Multilayered and Interconnected Genetic Mutations in Cancer

Supplementary Data, Figures 1-2 from Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in <i>Cosmc</i>

Supplementary Figures 1-2 from Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms

Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Supplementary Dataset 3 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression